Areteia Therapeutics
Chapel Hill, NC
Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eosinophilic asthma.
areteiatx.comCompany Details
Founded
- 2022
Employees
- Between 10 - 50 employees
Raised
- $425,000,000
Headquarters Location
- Chapel Hill, NC
Public
- No
Acquired
- No
CEO
Jorge Bartolome
Founders
- Whit BernardChristopher Courts, CPAJorge Bartolome
Company Collections
These are collections Areteia Therapeutics is a part of. Click on the collection name to view similar companies.
Areteia Therapeutics' Investors
Areteia Therapeutics' Industries
Areteia Therapeutics Headquarters Location
101 Glen Lennox Dr suite 300, Chapel Hill, NC 27517
Total Amount Raised: $425,000,000
Areteia Therapeutics' Investors
Areteia Therapeutics Funding Rounds
Series A
$75,000,000
Series A Investors
Bain Capital Life SciencesSaturn PartnersPopulation Health PartnersSanofi-AventisAccess IndustriesViking Global InvestorsGVMaverick CapitalArch Venture PartnersMarshall WaceSeries A
$350,000,000
Series A Investors
Bain Capital Life SciencesArch Venture PartnersMaverick CapitalGVPopulation Health PartnersAccess IndustriesSanofi-AventisSaturn Partners
Funding info provided by Diffbot.
Areteia Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Areteia Therapeutics.